中国核医学现状:首次官方全国调查
中国国家核医学质量控制中心于2020年开展首次官方调查,通过国家临床改进系统于2021年4月1日至5月31日收集数据,覆盖30个省份808家机构。调查揭示人力资源、设备与放射性核素治疗服务现状,结果作为建立质控管理体系的基础。
要点
- 共808家机构应答,覆盖30个省份,人力资源含医师4460名、技师3077名。
- SPECT或SPECT/CT共823台,PET/CT共314台;624家开展SPECT,319家开展PET。
- 587家提供放射性核素治疗但仅280家有收治病房。
核心结论
- 首次官方调查的中国核医学现状结果是建立质控管理体系的基础。
研究设计与样本
- 中国国家核医学质量控制中心开展首次官方调查,通过国家临床改进系统于2021年4月1日至5月31日进行网络调查,覆盖30个省份808家机构。
主要发现
- 人力资源包括医师4460名、技师3077名、物理师339名、放射化学师309名。
- 单光子显像设备887台,其中SPECT或SPECT/CT 823台;PET设备365台,其中PET/CT 314台。
- 624家机构开展SPECT检查,319家开展PET检查;SPECT扫描中60%为骨显像,PET扫描中97%使用[18F]F-FDG。
- 587家机构提供放射性核素治疗服务,但仅280家有收治病房。
- 放射性核素治疗前三位为[131I]治疗甲状腺功能亢进症546家、[89Sr]治疗骨转移400家、[131I]治疗分化型甲状腺癌286家。
关键数值与推荐
- 每省SPECT设备年均科内自检约67次,PET设备年均约111次;每省SPECT年均故障约3次,PET年均约5次。
- 624家SPECT机构中408家开展SPECT放射性药物质控,319家PET机构中216家开展PET放射性药物质控,587家治疗机构中373家开展治疗质控。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM/INTRODUCTION: The National Nuclear Medicine Quality Control Center of China conducted the first official survey to investigate the nationwide situation of nuclear medicine in 2020. The survey aimed to unveil the current nuclear medicine situation and its quality control in China. MATERIALS AND METHODS: The web-based survey was conducted and the data was collected via the National Clinical Improvement System (NCIS) of China from 1st April to 31st May 2021. RESULTS: A total of 808 institutes across 30 provinces responded to the national survey. For human resources, there are 4460 physicians, 3077 technologists, 339 physicists, and 309 radiochemists. There are 887 single-photon imaging instruments, including 823 SPECT or SPECT/CT, and 365 PET instruments including 314 PET/CT. Six hundred twenty-four institutes perform SPECT examinations and 319 institutes perform PET examinations. 60% of SPECT scans are bone scintigraphy. A total of 97% of PET scans use an [18F]F-FDG tracer. Furthermore, 587 institutes provide radionuclide therapy services but only 280 institutes have admission rooms. The top three radionuclide therapies are [131I] therapy of hyperthyroidism with 546 institutes, [89Sr] therapy of bone metastasis with 400 institutes, and [131I] therapy of differentiated thyroid cancer with 286 institutes. Finally, for the frequency of equipment quality control per year, there are about 67 times self-test within the department for SPECT instruments and 111 times for PET instruments on average in each province. There are about three failures of SPECT and five failures of PET on average per year in each province. There are 408 institutes (of 624 SPECT institutes) performing quality control of SPECT radiopharmaceuticals, 216 (of 319) for PET radiopharmaceuticals, and 373 (of 587) for radionuclide therapy. CONCLUSION: These results of the first official survey towards current status of nuclear medicine in China are the foundation for the establishment of the quality control management system.
引用
- Zhang H, Zheng J, Hu N, et al. The status of nuclear medicine in China: the first official national survey. Eur J Nucl Med Mol Imaging. 2024. PMID: 38561514. doi:10.1007/s00259-024-06687-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。